Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-26
DOI
10.3389/fcell.2020.00401
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
- (2020) Franziska Wandrer et al. Cell Death & Disease
- Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4+Foxp3+ induced Treg cells in vitro and in vivo periphery in autoimmune diseases
- (2019) Sujuan Yang et al. Cell Death & Disease
- Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
- (2019) Natalia Ortí-Casañ et al. Frontiers in Neuroscience
- TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity
- (2019) Juliane Medler et al. Cell Death & Disease
- Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injury
- (2019) Marcus J. Gerald et al. CNS Neuroscience & Therapeutics
- Systemic inhibition of soluble TNF with XPro1595 exacerbates a post-spinal cord injury depressive phenotype in female rats
- (2019) Kaitlin Farrell et al. JOURNAL OF NEUROTRAUMA
- Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc
- (2019) Fabian Richter et al. mAbs
- Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis
- (2019) Roman Fischer et al. BRAIN BEHAVIOR AND IMMUNITY
- Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches
- (2019) Madhu Sudhana Saddala et al. Journal of Translational Medicine
- Noncompetitive inhibitors of TNFR1 probe conformational activation states
- (2019) Chih Hung Lo et al. Science Signaling
- TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes
- (2019) Roman Fischer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice
- (2019) Minna Yli-Karjanmaa et al. Frontiers in Neuroscience
- Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling
- (2019) Pernille M. Madsen et al. BRAIN BEHAVIOR AND IMMUNITY
- Attenuating neurogenic sympathetic hyperreflexia robustly improves antibacterial immunity after chronic spinal cord injury
- (2019) Eugene Mironets et al. JOURNAL OF NEUROSCIENCE
- Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity
- (2019) Eric M. Tam et al. Science Translational Medicine
- Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes
- (2019) Maria Elizabeth De Sousa Rodrigues et al. Alzheimers Research & Therapy
- Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
- (2019) Tanja Padutsch et al. Frontiers in Pharmacology
- The E3 ubiquitin ligases HOIP and cIAP1 are recruited to the TNFR2 signaling complex and mediate TNFR2-induced canonical NF-κB signaling
- (2018) Alice Borghi et al. BIOCHEMICAL PHARMACOLOGY
- Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice
- (2018) Vanessa Lamontain et al. Cellular & Molecular Immunology
- TNF activity and T cells
- (2018) Amit K. Mehta et al. CYTOKINE
- Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease
- (2018) Sophie Steeland et al. EMBO Molecular Medicine
- The role of lymphotoxin-α in rheumatoid arthritis
- (2018) Tomohiro Hirose et al. INFLAMMATION RESEARCH
- Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-α-induced expression of nitric oxide synthase in dorsal root ganglion neurons
- (2018) Rong Tan et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury
- (2018) Eugene Mironets et al. JOURNAL OF NEUROSCIENCE
- Structural principles of tumor necrosis factor superfamily signaling
- (2018) Éva S. Vanamee et al. Science Signaling
- Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury
- (2018) Alastair Proudfoot et al. THORAX
- Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
- (2018) Meike Hutt et al. Oncotarget
- IgG-single-chain TRAIL fusion proteins for tumour therapy
- (2018) Martin Siegemund et al. Scientific Reports
- Structural principles of tumor necrosis factor superfamily signaling
- (2018) Éva S. Vanamee et al. Science Signaling
- Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis
- (2018) Roman Fischer et al. Arthritis & Rheumatology
- Selective Modulation of TNF–TNFRs Signaling: Insights for Multiple Sclerosis Treatment
- (2018) Valentina Pegoretti et al. Frontiers in Immunology
- The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4+Foxp3+ Regulatory T Cells
- (2018) Tianzhen He et al. Frontiers in Immunology
- TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
- (2018) Yuqiao Sheng et al. Frontiers in Immunology
- The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells
- (2018) Lin-Lin Ye et al. Frontiers in Immunology
- Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity
- (2018) Fabian Richter et al. mAbs
- TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway
- (2018) Jun Wang et al. Scientific Reports
- Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
- (2018) Sarah K. Williams et al. Scientific Reports
- Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
- (2018) H Torrey et al. LEUKEMIA
- TNFR1 inhibition is therapeutic for neuropathic pain in males but not females
- (2018) Tania del Rivero et al. PAIN
- Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity
- (2018) Kamar-Sulu N. Atretkhany et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification
- (2017) Masaki Inoue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice
- (2017) Kathryn P. MacPherson et al. NEUROBIOLOGY OF DISEASE
- Inhibition of TNF reduces mechanical orofacial hyperalgesia induced by Complete Freund’s Adjuvant by a TRPV1-dependent mechanism in mice
- (2017) Krzysztof Lis et al. Pharmacological Reports
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- TNFR2: A Novel Target for Cancer Immunotherapy
- (2017) Éva S. Vanamee et al. TRENDS IN MOLECULAR MEDICINE
- Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
- (2017) Roman Fischer et al. Scientific Reports
- Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2017) Han Gao et al. Cell Reports
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation
- (2017) Tobias Schmid et al. Frontiers in Immunology
- An Innovative High-Throughput Screening Approach for Discovery of Small Molecules That Inhibit TNF Receptors
- (2017) Chih Hung Lo et al. SLAS Discovery
- TNFR1 inhibition with a Nanobody protects against EAE development in mice
- (2017) Sophie Steeland et al. Scientific Reports
- Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
- (2016) Martin Chopra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination
- (2016) Pernille M. Madsen et al. JOURNAL OF NEUROSCIENCE
- Genetic Ablation of Soluble TNF Does Not Affect Lesion Size and Functional Recovery after Moderate Spinal Cord Injury in Mice
- (2016) Ditte Gry Ellman et al. MEDIATORS OF INFLAMMATION
- RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis
- (2016) P. Bru nker et al. MOLECULAR CANCER THERAPEUTICS
- Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration
- (2016) Yun Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response
- (2016) Phillip D. Fromm et al. Frontiers in Microbiology
- TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis
- (2016) Xin Chen et al. Scientific Reports
- Specificity of human anti-variable heavy (VH) chain autoantibodies and impact on the design and clinical testing of a VHdomain antibody antagonist of tumour necrosis factor-α receptor 1
- (2015) J. C. Cordy et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Aminopeptidase P3, a new member of the TNF-TNFR2 signaling complex, induces phosphorylation of JNK1 and JNK2
- (2015) M. Inoue et al. JOURNAL OF CELL SCIENCE
- Transmembrane TNF–TNFR2 Impairs Th17 Differentiation by PromotingIl2Expression
- (2015) Patrick G. Miller et al. JOURNAL OF IMMUNOLOGY
- Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
- (2015) Roman Fischer et al. Oxidative Medicine and Cellular Longevity
- Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension
- (2015) Laura J. Goodall et al. PLoS One
- FRI0231 Atrosab, a humanized antibody directed against tnf-receptor 1, hold great promises for the treatment of rheumatoid arthritis
- (2014) E. Guenzi et al. ANNALS OF THE RHEUMATIC DISEASES
- Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling
- (2014) Anna Dellarole et al. BRAIN BEHAVIOR AND IMMUNITY
- Lymphotoxin and TNF: How it all began—A tribute to the travelers
- (2014) Nancy H. Ruddle CYTOKINE & GROWTH FACTOR REVIEWS
- Anti-TNF therapy: past, present and future
- (2014) C. Monaco et al. INTERNATIONAL IMMUNOLOGY
- Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1
- (2014) Sophie Steeland et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity
- (2014) A. Krippner-Heidenreich et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells
- (2014) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
- (2014) Bettina Hjelm Clausen et al. Journal of Neuroinflammation
- Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice
- (2014) Hans G Novrup et al. Journal of Neuroinflammation
- TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction
- (2014) F Van Hauwermeiren et al. Mucosal Immunology
- Regulated necrosis: the expanding network of non-apoptotic cell death pathways
- (2014) Tom Vanden Berghe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Distinct role of tumor necrosis factor receptor subtypes 1 and 2 in the red nucleus in the development of neuropathic pain
- (2014) Xiao-Yan Zeng et al. NEUROSCIENCE LETTERS
- Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis
- (2014) Sarah K. Williams et al. PLoS One
- Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)
- (2014) William P Kennedy et al. ARTHRITIS RESEARCH & THERAPY
- TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress
- (2013) Olaf Maier et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo
- (2013) David A. Horwitz et al. CLINICAL IMMUNOLOGY
- Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor
- (2013) Roman Fischer et al. GLIA
- Autoantibodies to Variable Heavy (VH) Chain Ig Sequences in Humans Impact the Safety and Clinical Pharmacology of a VH Domain Antibody Antagonist of TNF-α Receptor 1
- (2013) M. C. Holland et al. JOURNAL OF CLINICAL IMMUNOLOGY
- TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment
- (2013) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
- (2013) Fabian Richter et al. PLoS One
- Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
- (2013) Yoshiaki Okubo et al. Scientific Reports
- Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS
- (2012) Jigisha R. Patel et al. ACTA NEUROPATHOLOGICA
- No one can whistle a symphony alone - how different ubiquitin linkages cooperate to orchestrate NF- B activity
- (2012) A. C. Schmukle et al. JOURNAL OF CELL SCIENCE
- Tumor Necrosis Factor Activation of Vagal Afferent Terminal Calcium Is Blocked by Cannabinoids
- (2012) R. C. Rogers et al. JOURNAL OF NEUROSCIENCE
- The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand
- (2012) C. Richter et al. MOLECULAR AND CELLULAR BIOLOGY
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
- (2012) Adam P. Gregory et al. NATURE
- Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning
- (2011) Yasuhiro Abe et al. BIOMATERIALS
- Heterogeneity reduces sensitivity of cell death for TNF-Stimuli
- (2011) Monica Schliemann et al. BMC Systems Biology
- Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
- (2011) Roberta Brambilla et al. BRAIN
- Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-κB
- (2011) Era Taoufik et al. BRAIN
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- TNFR2 on non-haematopoietic cells is required for Foxp3+Treg-cell function and disease suppression in EAE
- (2011) Niki Tsakiri et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TNFR1-induced activation of the classical NF-κB pathway
- (2011) Harald Wajant et al. FEBS Journal
- Novel TNF-α Receptor 1 Antagonist Treatment Attenuates Arterial Inflammation and Intimal Hyperplasia in Mice
- (2011) Manabu Kitagaki et al. Journal of Atherosclerosis and Thrombosis
- A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
- (2011) Roman Fischer et al. PLoS One
- Fluorescence correlation spectroscopy reveals topological segregation of the two tumor necrosis factor membrane receptors
- (2010) Margarita Gerken et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2
- (2010) Verena Boschert et al. CELLULAR SIGNALLING
- Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway
- (2010) Roman Fischer et al. CELLULAR SIGNALLING
- Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+regulatory T cells in human peripheral blood
- (2010) Xin Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Acquisition of regulatory function by human CD8+ T cells treated with anti-CD3 antibody requires TNF
- (2010) Vitaly Ablamunits et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis
- (2010) Maria L. Olleros et al. JOURNAL OF HEPATOLOGY
- Expression of Costimulatory TNFR2 Induces Resistance of CD4+FoxP3- Conventional T Cells to Suppression by CD4+FoxP3+ Regulatory T Cells
- (2010) X. Chen et al. JOURNAL OF IMMUNOLOGY
- ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody
- (2010) Kirstin A. Zettlitz et al. mAbs
- Delayed Dominant-Negative TNF Gene Therapy Halts Progressive Loss of Nigral Dopaminergic Neurons in a Rat Model of Parkinson's Disease
- (2010) Ashley S Harms et al. MOLECULAR THERAPY
- Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain
- (2010) C. Geis et al. NEUROSCIENCE
- TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: Distinct role of TNF receptor subtypes 1 and 2
- (2010) Ling Zhang et al. PAIN
- ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ treg cells and induces sustained amelioration of collagen-induced arthritis
- (2009) Clare A. Notley et al. ARTHRITIS AND RHEUMATISM
- The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF
- (2009) Hiroko Shibata et al. BIOMATERIALS
- Divergent Tumor Necrosis Factor Receptor–Related Remodeling Responses in Heart Failure
- (2009) Tariq Hamid et al. CIRCULATION
- Antagonists of TNF action: clinical experience and new developments
- (2009) Roland E Kontermann et al. Expert Opinion on Drug Discovery
- Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)
- (2009) Hilka Rauert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice
- (2009) Tetsuya Nomura et al. JOURNAL OF CONTROLLED RELEASE
- A Humanized Tumor Necrosis Factor Receptor 1 (TNFR1)-specific Antagonistic Antibody for Selective Inhibition of Tumor Necrosis Factor (TNF) Action
- (2009) Roland E. Kontermann et al. JOURNAL OF IMMUNOTHERAPY
- Dominant‐Negative Tumor Necrosis Factor Protects fromMycobacterium bovisBacillus Calmette‐Guérin (BCG) and Endotoxin‐Induced Liver Injury without Compromising Host Immunity to BCG andMycobacterium tuberculosis
- (2009) Maria L. Olleros et al. JOURNAL OF INFECTIOUS DISEASES
- Nanoscale Arrangement of Apoptotic Ligands Reveals a Demand for a Minimal Lateral Distance for Efficient Death Receptor Activation
- (2009) Julia Ranzinger et al. NANO LETTERS
- Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology
- (2009) Fiona E. McAlpine et al. NEUROBIOLOGY OF DISEASE
- Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
- (2008) Robbert G. van der Most et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The therapeutic effect of TNFR1-selective antagonistic mutant TNF-α in murine hepatitis models
- (2008) Hiroko Shibata et al. CYTOKINE
- Structure–Function Relationship of Tumor Necrosis Factor (TNF) and Its Receptor Interaction Based on 3D Structural Analysis of a Fully Active TNFR1-Selective TNF Mutant
- (2008) Yohei Mukai et al. JOURNAL OF MOLECULAR BIOLOGY
- TNF-α mediates neuroprotection against glutamate-induced excitotoxicity via NF-κB-dependent up-regulation of KCa2.2 channels
- (2008) Amalia M. Dolga et al. JOURNAL OF NEUROCHEMISTRY
- Endogenous Tumor Necrosis Factor (TNF ) Requires TNF Receptor Type 2 to Generate Heat Hyperalgesia in a Mouse Cancer Model
- (2008) C. E. Constantin et al. JOURNAL OF NEUROSCIENCE
- Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian rats
- (2008) Melissa K McCoy et al. MOLECULAR THERAPY
- Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism
- (2008) L. Ban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started